Brief: Newlink Genetics Corp QTRLY Loss Per Share $0.22
28/02/2020 14:08
Feb 28 (Reuters) - NewLink Genetics Corp NLNK.O :
* NEWLINK GENETICS CORP QTRLY LOSS PER SHARE $0.22
* NEWLINK GENETICS - ENDED YEAR ON DEC 31, 2019, WITH CASH &
CASH
EQUIVALENTS TOTALING $90.5 MILLION COMPARED TO $120.7 MILLION
FOR YEAR ENDING DEC 31, 2018
Source text for Eikon: ID:nGNX4pcLg6
Further company coverage: NLNK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)